Carole Fry

1.8k total citations
18 papers, 1.0k citations indexed

About

Carole Fry is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Carole Fry has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Applied Microbiology and Biotechnology and 3 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Carole Fry's work include Antibiotic Use and Resistance (5 papers), Infection Control in Healthcare (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Carole Fry is often cited by papers focused on Antibiotic Use and Resistance (5 papers), Infection Control in Healthcare (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Carole Fry collaborates with scholars based in United Kingdom, Ireland and France. Carole Fry's co-authors include John Coia, H. Humphreys, D.R. Tucker, G. Duckworth, M. Farrington, David Edwards, C. Mallaghan, Mark H. Wilcox, Alan P. Johnson and G.L. French and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Journal of Medical Microbiology and Journal of Hospital Infection.

In The Last Decade

Carole Fry

17 papers receiving 988 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carole Fry United Kingdom 11 477 284 249 215 207 18 1.0k
Lynn Johnston Canada 20 519 1.1× 349 1.2× 155 0.6× 150 0.7× 140 0.7× 40 1.2k
Niccolò Buetti Switzerland 20 414 0.9× 346 1.2× 237 1.0× 212 1.0× 240 1.2× 97 1.5k
Sharon B. Wright United States 22 432 0.9× 536 1.9× 247 1.0× 280 1.3× 164 0.8× 53 1.3k
Irina Zuschneid Germany 15 403 0.8× 303 1.1× 342 1.4× 112 0.5× 122 0.6× 23 980
Bernard Camins United States 20 628 1.3× 331 1.2× 128 0.5× 278 1.3× 268 1.3× 59 1.2k
Christiane Pétignat Switzerland 21 465 1.0× 323 1.1× 278 1.1× 237 1.1× 140 0.7× 52 1.3k
Caroline Landelle France 16 292 0.6× 424 1.5× 232 0.9× 108 0.5× 163 0.8× 62 1.0k
Jane Briggs United States 6 561 1.2× 259 0.9× 130 0.5× 321 1.5× 117 0.6× 9 2.2k
Paulo Pinto Gontijo Filho Brazil 24 481 1.0× 219 0.8× 208 0.8× 192 0.9× 140 0.7× 84 1.3k
Sarah S. Lewis United States 20 619 1.3× 374 1.3× 172 0.7× 119 0.6× 149 0.7× 91 1.5k

Countries citing papers authored by Carole Fry

Since Specialization
Citations

This map shows the geographic impact of Carole Fry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carole Fry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carole Fry more than expected).

Fields of papers citing papers by Carole Fry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carole Fry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carole Fry. The network helps show where Carole Fry may publish in the future.

Co-authorship network of co-authors of Carole Fry

This figure shows the co-authorship network connecting the top 25 collaborators of Carole Fry. A scholar is included among the top collaborators of Carole Fry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carole Fry. Carole Fry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jones, Christopher R., Andrew M. Borman, Emma Budd, et al.. (2024). The laboratory investigation, management, and infection prevention and control of Candida auris: a narrative review to inform the 2024 national guidance update in England. Journal of Medical Microbiology. 73(5). 15 indexed citations
2.
Fry, Carole, C.R. Bradley, Thomas Pottage, et al.. (2022). Automated room decontamination: report of a Healthcare Infection Society Working Party. Journal of Hospital Infection. 124. 97–120. 10 indexed citations
3.
Puleston, Richard, Colin Brown, Bharat Patel, et al.. (2020). Recommendations for detection and rapid management of carbapenemase-producing Enterobacterales outbreaks. Infection Prevention in Practice. 2(3). 100086–100086. 2 indexed citations
4.
Denton, Andrea, Carole Fry, Helen O’Connor, & Jude Robinson. (2019). Revised Infection Prevention Society (IPS) Competences 2018. Journal of Infection Prevention. 20(1). 18–24. 3 indexed citations
5.
Duerden, B. I., Carole Fry, Alan P. Johnson, & Mark H. Wilcox. (2015). The Control of Methicillin-Resistant Staphylococcus aureus Blood Stream Infections in England. Open Forum Infectious Diseases. 2(2). ofv035–ofv035. 59 indexed citations
6.
Coia, John, Lisa M. Puchalski Ritchie, & Carole Fry. (2014). Use of respiratory and facial protection.. PubMed. 110(4). 18–20. 1 indexed citations
7.
Cooke, Jonathan, Diane Ashiru‐Oredope, Esmita Charani, et al.. (2014). Longitudinal trends and cross-sectional analysis of English national hospital antibacterial use over 5 years (2008-13): working towards hospital prescribing quality measures. Journal of Antimicrobial Chemotherapy. 70(1). 279–285. 23 indexed citations
8.
Coia, John, Anil Adisesh, Catherine Booth, et al.. (2013). Guidance on the use of respiratory and facial protection equipment. Journal of Hospital Infection. 85(3). 170–182. 104 indexed citations
9.
Wickens, Hayley, Sarah P. Farrell, Diane Ashiru‐Oredope, et al.. (2013). The increasing role of pharmacists in antimicrobial stewardship in English hospitals. Journal of Antimicrobial Chemotherapy. 68(11). 2675–2681. 86 indexed citations
10.
Anthony, Mark, Tracey Cooper, Carole Fry, et al.. (2013). Managing and preventing outbreaks of Gram-negative infections in UK neonatal units. Archives of Disease in Childhood Fetal & Neonatal. 98(6). F549–F553. 38 indexed citations
11.
Fry, Carole. (2012). Antimicrobial resistance, responsible prescribing – a call to action for nurses. Journal of Infection Prevention. 13(6). 182–182. 1 indexed citations
12.
Masterton, R.G., A. Galloway, G.L. French, et al.. (2008). Guidelines for the management of hospital-acquired pneumonia in the UK: Report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy. 62(1). 5–34. 219 indexed citations
13.
Humphreys, H., Robert G. Newcombe, J.E. Enstone, et al.. (2008). Four Country Healthcare Associated Infection Prevalence Survey 2006: risk factor analysis. Journal of Hospital Infection. 69(3). 249–257. 53 indexed citations
14.
Coia, John, G. Duckworth, David Edwards, et al.. (2006). Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. Journal of Hospital Infection. 63. S1–S44. 401 indexed citations
15.
Morgan, Maria, Jennifer Ann Black, Carole Fry, et al.. (2005). Clinician-led surgical site infection surveillance of orthopaedic procedures: a UK multi-centre pilot study. Journal of Hospital Infection. 60(3). 201–212. 12 indexed citations
16.
17.
Pratt, Robert, et al.. (2002). Healthcare governance and the modernisation of the NHS: infection prevention and control. 3(5). 16–25. 6 indexed citations
18.
Hannan, Margaret M., et al.. (1996). An outbreak of Salmonella enteritidis in a maternity and neonatal intensive care unit. Journal of Hospital Infection. 34(2). 117–122. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026